Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Clinical trial NCT06309966 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06309966
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2026-10-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.